Handelsbanken Fonder Ab Incyte Corp Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Incyte Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 86,317 shares of INCY stock, worth $6.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

86,317

Previous 86,392 0.09%

Holding current value

$6.13 Million

Previous $5.24 Million 8.96%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$57.33 - $68.61 $4,299 - $5,145	-75 Reduced 0.09%	86,317 $5.71 Million
Q2 2024 Aug 05, 2024	SELL	$51.18 - $63.75 $922,110 - $1.15 Million	-18,017 Reduced 17.26%	86,392 $5.24 Million
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $149,065 - $175,531	2,636 Added 2.59%	104,409 $5.95 Million
Q4 2023 Feb 01, 2024	SELL	$52.16 - $64.19 $1.25 Million - $1.54 Million	-23,976 Reduced 19.07%	101,773 $6.39 Million
Q3 2023 Oct 19, 2023	BUY	$57.77 - $65.93 $8,665 - $9,889	150 Added 0.12%	125,749 $7.27 Million
Q2 2023 Aug 02, 2023	BUY	$60.95 - $75.51 $265,437 - $328,846	4,355 Added 3.59%	125,599 $7.82 Million
Q1 2023 Apr 28, 2023	BUY	$70.23 - $86.01 $469,557 - $575,062	6,686 Added 5.84%	121,244 $8.76 Million
Q4 2022 Feb 07, 2023	BUY	$67.18 - $84.11 $114,206 - $142,987	1,700 Added 1.51%	114,558 $9.2 Million
Q3 2022 Oct 27, 2022	BUY	$66.18 - $82.86 $388,807 - $486,802	5,875 Added 5.49%	112,858 $7.52 Million
Q2 2022 Aug 03, 2022	BUY	$66.18 - $83.18 $1.72 Million - $2.16 Million	26,005 Added 32.11%	106,983 $8.13 Million
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $290,025 - $350,166	4,393 Added 5.74%	80,978 $6.43 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $293,960 - $343,944	4,641 Added 6.45%	76,585 $5.62 Million
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $234,645 - $287,096	3,417 Added 4.99%	71,944 $4.95 Million
Q2 2021 Aug 03, 2021	BUY	$79.87 - $87.53 $2.06 Million - $2.25 Million	25,748 Added 60.19%	68,527 $5.77 Million
Q1 2021 Apr 29, 2021	BUY	$76.02 - $100.5 $60,816 - $80,400	800 Added 1.91%	42,779 $3.48 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $93,576 - $120,659	1,100 Added 2.69%	41,979 $3.77 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $3.03 Million - $4.45 Million	40,879 New	40,879 $4.25 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Incyte Corp Transaction History